Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion

Παρόμοια τεκμήρια

• 74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
  ανά: Barnett, G, κ.ά.
  Έκδοση: (2014)
• Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions
  ανά: Barnett, G, κ.ά.
  Έκδοση: (2012)
• The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
  ανά: Barnett, G, κ.ά.
  Έκδοση: (2013)
• UPREGULATION OF HYPDXIA-INDUCIBLE FACTOR 1 alpha BY DI-METHYL OXALYL GLYCINE PROMOTES ANGIOGENESIS WITHIN ISCHAEMIC MYOCARDIUM IN A PORCINE CORONARY OCCLUSION MODEL
  ανά: Kelly, D, κ.ά.
  Έκδοση: (2010)
• In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish
  ανά: Kelly, D, κ.ά.
  Έκδοση: (2008)